Effects of insulin and 2-deoxy-D-glucose administration on CNS IGF-II content

Brain Res Bull. 1994;34(5):493-8. doi: 10.1016/0361-9230(94)90023-x.

Abstract

In order to determine whether effects of insulin on central nervous system (CNS) insulin-like growth factor II (IGF-II) content are direct or whether they are due to insulin-induced glucoprivation, short-term (2 h) time course studies were conducted utilizing the glucoprivic agent 2-deoxy-D-glucose (2-DG). Insulin (2 U/kg b.wt.), 2-DG (500 mg/kg b.wt.) or vehicle were administered to Sprague-Dawley rats (350-450 kg) and groups of animals were killed at time 0 and 15, 30, 45, 60, and 120 min following injection. Specific hypothalamic and hindbrain regions obtained by microdissection, were analyzed for IGF-II content by RIA. Insulin and 2-DG exerted similar effects on IGF-II content in the dorsomedial hypothalamus and the paraventricular nucleus. These data suggest that IGF-II was primarily regulated by glucoprivation in these regions. Only 2-DG altered ventromedial hypothalamic IGF-II content, and opposite responses to the two agents were observed in the arcuate nucleus. This uncoupling of IGF-II response suggests that differences in peripheral vs. central signals for IGF-II secretion may be involved. The vagal complex was responsive only to insulin injection indicating a specific response that may be tied to sensory vagal function.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Blood Glucose / analysis
  • Brain / metabolism*
  • Deoxyglucose / pharmacology*
  • Insulin / blood
  • Insulin / pharmacology*
  • Insulin-Like Growth Factor II / metabolism*
  • Osmolar Concentration
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Blood Glucose
  • Insulin
  • Insulin-Like Growth Factor II
  • Deoxyglucose